Beneficial ownership — 13D / 13G
87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | CRI Carters Inc | 13G/A | 10.01% | May 31, 2024 | 2y |
| T. Rowe Price Investment Management, Inc. | AMPL Amplitude, Inc. | 13G/A | 10.1% | May 31, 2024 | 2y |
| GATE CITY CAPITAL MANAGEMENT, LLC | ALCO Alico, Inc. | 13G/A | 10.9% | May 31, 2024 | 2y |
| Driehaus Capital Management LLC | AAOI Applied Optoelectronics, Inc. | 13G/A | 2.17% | May 31, 2024 | 2y |
| VANGUARD GROUP INC | QCOM Qualcomm Inc | 13G/A | 10.03% | May 31, 2024 | 2y |
| GLAZER CAPITAL, LLC | BOCN Blue Ocean Acquisition Corp Class A Ordinary Shares | 13G | 10.86% | May 31, 2024 | 2y |
| First Light Asset Management, LLC | TELA TELA Bio, Inc. | 13G/A | 0% | May 31, 2024 | 2y |
| BIOTECHNOLOGY VALUE FUND L P | CELC Celcuity Inc. | 13G | 9.9% | May 30, 2024 | 2y |
| Beryl Capital Management LLC | SRDX Surmodics, Inc. Common Stock | 13G | 7.4% | May 30, 2024 | 2y |
| Madison Avenue Partners, LP | MDRX Veradigm Inc. Common Stock | 13G | 5.7% | May 29, 2024 | 2y |
| Kunpeng Tech Limited | KPEA Kun Peng International Ltd. | 13D | 10.86% | May 23, 2024 | 2y |
| Kun Peng XJ Limited | KPEA Kun Peng International Ltd. | 13D | 9.98% | May 23, 2024 | 2y |
| Kungpeng TJ Limited | KPEA Kun Peng International Ltd. | 13D/A | 21% | May 23, 2024 | 2y |
| Pui Chun Wong | KPEA Kun Peng International Ltd. | 13D/A | 35.02% | May 23, 2024 | 2y |
| Lighthouse Investment Partners, LLC | FRLA Fortune Rise Acquisition Corporation Class A Common Stock | 13G/A | 13.25% | Jun 2, 2023 | 2y |
| John J. Fisher | GAP Gap Inc | 13D/A | 15.9% | Jun 7, 2024 | 2y |
| Soleus Capital Master Fund, L.P. | TERN Terns Pharmaceuticals, Inc. | 13G | 5.2% | Jun 6, 2024 | 2y |
| Osmium Partners, LLC | TBHC BRAND HOUSE COLLECTIVE, INC. | 13D/A | 9.7% | Jun 6, 2024 | 2y |
| Christopher D. Maggiore | ZIVO Zivo Bioscience, Inc. | 13D/A | 14% | Jun 5, 2024 | 2y |
| Shasta Ventures II GP, LLC | NXDR Nextdoor Holdings, Inc. | 13D/A | 4.7% | Jun 5, 2024 | 2y |
| Peter J. Werth | CING Cingulate Inc. | 13D/A | 17.05% | Jun 5, 2024 | 2y |
| Saba Capital Management, L.P. | GNT GAMCO Natural Resources, Gold & Income Trust | 13D/A | 10.7% | Jun 5, 2024 | 2y |
| GLOBAL VALUE INVESTMENT CORP. | FLNT Fluent, Inc. | 13D/A | 7.26% | Jun 5, 2024 | 2y |
| J. Nicholas Ayers | PSQH PSQ Holdings, Inc. | 13D/A | 4.4% | Jun 5, 2024 | 2y |
| Theofilos Charles Steve | ECOR electroCore, Inc. | 13D/A | 6.5% | Jun 5, 2024 | 2y |
| PADDON PATRICK E | CFNB California First Leasing Corp | 13G | 55.3% | Jun 4, 2024 | 2y |
| WPGG 14 Investment Ltd. IV | DCBO Docebo Inc. | 13G/A | 10.41% | Jun 4, 2024 | 2y |
| PL Capital Advisors, LLC | EVBN Evans Bancorp Inc | 13D/A | 11% | Jun 4, 2024 | 2y |
| BlackRock Inc. | RIVN Rivian Automotive, Inc. | 13G/A | 4.7% | May 31, 2024 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 0% | May 31, 2024 | 2y |
| BAILLIE GIFFORD & CO | HCP HashiCorp, Inc. Class A Common Stock | 13G/A | 3.91% | May 31, 2024 | 2y |
| BlackRock Inc. | FHI Federated Hermes, Inc. | 13G/A | 10.2% | May 31, 2024 | 2y |
| BlackRock Inc. | FCNCA First Citizens Bancshares Inc | 13G/A | 10.7% | May 31, 2024 | 2y |
| BlackRock Inc. | SRPT Sarepta Therapeutics, Inc. | 13G/A | 10.7% | May 31, 2024 | 2y |
| BlackRock Inc. | AMG Affiliated Managers Group, Inc. | 13G/A | 10.2% | May 31, 2024 | 2y |
| BlackRock Inc. | BAI BlackRock ETF Trust | 13G/A | 54.3% | May 31, 2024 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 10.4% | May 31, 2024 | 2y |
| BlackRock Inc. | COFS Choiceone Financial Services Inc | 13G/A | 4.97% | May 31, 2024 | 2y |
| JPMORGAN CHASE & CO | CRI Carters Inc | 13G/A | 10.3% | May 31, 2024 | 2y |
| BAILLIE GIFFORD & CO | DOCS Doximity, Inc. | 13G/A | 4.95% | May 31, 2024 | 2y |
| BlackRock Inc. | AYI Acuity Inc. (De) | 13G/A | 10.7% | May 31, 2024 | 2y |
| BlackRock Inc. | EBS Emergent BioSolutions Inc. | 13G/A | 12.7% | May 31, 2024 | 2y |
| Samir R. Patel | AKTX Akari Therapeutics Plc | 13D | 14.5% | May 31, 2024 | 2y |
| METEORA CAPITAL, LLC | IVCB Investcorp Europe Acquisition Corp I Class A Ordinary Shares | 13G | 11.07% | May 31, 2024 | 2y |
| BlackRock Inc. | JOE ST JOE Co | 13G/A | 10.4% | May 31, 2024 | 2y |
| BlackRock Inc. | POWW Outdoor Holding Co | 13G/A | 5% | May 31, 2024 | 2y |
| BlackRock Inc. | AAXJ iShares Trust | 13G/A | 13.3% | May 31, 2024 | 2y |
| LFP Management, LLC | INTS Intensity Therapeutics, Inc. | 13G | 5.4% | May 31, 2024 | 2y |
| Capital World Investors | GTLS Chart Industries Inc | 13G/A | 4.7% | May 31, 2024 | 2y |
| JPMORGAN CHASE & CO | NGL NGL Energy Partners LP | 13G/A | 4.1% | May 31, 2024 | 2y |